ACXP News and Press, Acurx Pharmaceuticals Inc. From 01/19/24

NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing episode 550 on the FOX Business Network , Monday, January 22, 2024, at 10:30 PM PT. New to The Street's 550 th TV epis...

2024-01-18 08:24:12 ET More on pre-market losers & stocks. Cytosorbents Corporation (CTSO) Q3 2023 Earnings Call Transcript Psyence's unit signs deal for up to $10M in funding via issuance of convertible notes Dawson James sees Cytosorbents' Cytosorb as approvabl...

2024-01-17 11:49:53 ET More on Acurx Pharmaceuticals Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Call Transcript Acurx Undervalued And Set For Potential M&A With Next-Gen C. Diff Treatment ELAB, KIND and RLX among pre-market losers Acurx spikes af...

2024-01-17 10:00:18 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Health stocks to watch this earnings season as sector poised for resurgence Seeking Al...

2024-01-17 09:00:32 ET Losers: DatChat DATS -32% plans to sell shares through public offering . Acurx Pharmaceuticals ( NASDAQ: ACXP ) -24% announces positive comparative Microbiology and Microbiome data for Ibezapolstat from phase 2b clinical trial in CDI ...

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients PR Newswire Ibezapolstat outperformed vancomycin showing eradication of fecal C. difficile at Day 3 of treatment in 15 of 16 treated patients...

NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street , a nationally broadcasted TV show, announces episode 543, airing on the Fox Business Network , Monday, January 8, 2024, at 10:30 PM PT. New to The Street's 543rd TV episode line-up features the following ...

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire STATEN ISLAND, N.Y. , Jan. 3, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company") today announced that President and ...

2023-12-12 10:00:27 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Achieve Life S...

2023-12-12 08:39:32 ET Losers: Achieve Life Sciences ( ACHV ) -24% announces participation at upcoming investor conferences. Clearmind Medicine CMND -13% files for $50M mixed shelf . Oracle Corp. ORCL -10% after Q2 earnings release . Acurx Pharmaceu...